Safety and Efficacy of IDP-118 Lotion in the Treatment of Plaque Psoriasis
Public ClinicalTrials.gov record NCT02785159. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Multicenter, Double Blinded, Randomized, Vehicle Controlled Study to Compare the Safety and Efficacy of IDP-118 Lotion With Tazorac (Tazarotene) Cream, 0.05% in the Treatment of Plaque Psoriasis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Safety and Efficacy of IDP-118 Lotion in the Treatment of Plaque Psoriasis
Study identification
- NCT ID
- NCT02785159
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 152 participants
Conditions and interventions
Conditions
Interventions
- IDP-118 Lotion Drug
- Tazorac Cream Drug
- IDP-118 Vehicle Lotion Drug
- IDP-118 Vehicle Cream Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 2016 (Type not available)
- Primary completion
- Nov 20, 2016 (Actual)
- Completion
- Dec 2016 (Actual)
- Last update posted
- Aug 20, 2020
2016
United States locations
- U.S. sites
- 14
- U.S. states
- 10
- U.S. cities
- 13
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Valeant Site 12 | Encino | California | 91316 | — |
| Valeant Site 13 | Orange Park | Florida | 32065 | — |
| Valeant Site 11 | Pinellas Park | Florida | 33780 | — |
| Valeant Site 01 | Tampa | Florida | 33601 | — |
| Valeant Site 04 | Tampa | Florida | 33601 | — |
| Valeant Site 05 | Plainfield | Indiana | 46168 | — |
| Valeant Site 09 | Clarkston | Michigan | 48346 | — |
| Valeant Site 07 | Fridley | Minnesota | 55421 | — |
| Valeant Site 14 | Saint Joseph | Missouri | 64501 | — |
| Valeant Site 10 | Greenville | South Carolina | 29601 | — |
| Valeant Site 03 | Murfreesboro | Tennessee | 37129 | — |
| Valeant Site 06 | College Station | Texas | 77840 | — |
| Valeant Site 08 | Webster | Texas | 77598 | — |
| Valeant Site 02 | Charlottesville | Virginia | 22901 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02785159, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 20, 2020 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02785159 live on ClinicalTrials.gov.